![]() ![]() You should not take Talicia if you are known to be sensitive to any of the components of Talicia (omeprazole, amoxicillin, rifabutin), penicillins, proton pump inhibitors or rifamycins.Do not start any new medications while taking Talicia without first speaking with your healthcare provider. Talicia may affect the way other medicines work, and other medicines may affect the way Talicia works. To report SUSPECTED ADVERSE REACTIONS, contact Salix Pharmaceuticals at 1-80 or FDA at 1-80 or Please click here for full Prescribing Information.Tell your healthcare provider about all of the medicines you take, including prescription or non-prescription medications or herbal supplements before starting Talicia. Advise pregnant women of the potential risk to a fetus. Dose adjustment of warfarin may be required. INR changes have been reported in patients receiving rifaximin and warfarin concomitantly.In clinical studies, the most common adverse reactions for XIFAXAN were:.In patients with hepatic impairment, a potential additive effect of reduced metabolism and concomitant P-gp inhibitors may further increase the systemic exposure to rifaximin. Concomitant administration of cyclosporine, an inhibitor of P-gp and OATPs, significantly increased the systemic exposure of rifaximin. Caution should be exercised when concomitant use of XIFAXAN and P-glycoprotein (P-gp) and/or OATPs inhibitors is needed.Caution should be exercised when administering XIFAXAN to these patients. There is an increased systemic exposure in patients with severe (Child-Pugh Class C) hepatic impairment.If CDAD is suspected or confirmed, ongoing antibiotic use not directed against C. Clostridium difficile-associated diarrhea (CDAD) has been reported with use of nearly all antibacterial agents, including XIFAXAN, and may range in severity from mild diarrhea to fatal colitis.Hypersensitivity reactions have included exfoliative dermatitis, angioneurotic edema, and anaphylaxis. XIFAXAN is contraindicated in patients with a hypersensitivity to rifaximin, rifamycin antimicrobial agents, or any of the components in XIFAXAN.Visit or call 1-866-XIFAXAN for full eligibility criteria, terms and conditions. Maximum benefits and other restrictions apply. ![]() Offer excludes full cash-paying patients. Patient must be enrolled in, and must seek reimbursement from or submit a claim for reimbursement to, a commercial insurance plan. ||Patient is not eligible if he/she participates in or seeks reimbursement or submits a claim for reimbursement to any federal or state healthcare program with prescription drug coverage, such as Medicaid, Medicare, Medigap, VA, DOD, TRICARE, or any similar federal or state healthcare program (each a Government Program), or where prohibited by law. Salix Pharmaceuticals does not guarantee coverage or reimbursement for the product. It is the treating physician’s responsibility to determine the proper diagnosis, treatment, and applicable ICD-10 code. Patient-access–related information are provided for informational purposes only. †Salix Pharmaceuticals does not guarantee coverage or reimbursement for the product. As a reminder, it is the responsibility of the healthcare professional and/or their office staff, as appropriate, to determine the correct diagnosis, treatment protocol, and content of all such forms for each individual patient. *NOTE: These sample forms are provided for informational purposes only. IBS-D, irritable bowel syndrome with diarrhea OHE, overt hepatic encephalopathy. ![]()
0 Comments
Leave a Reply. |